We are live on ! Find out more
Morgan Stanley

Morgan Stanley Portfolio holdings

AUM $1.89T
1-Year Est. Return 35.08%
 

Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.

This Fund
S&P 500
This Quarter Est. Return
-3.97%
1 Year Est. Return
+35.08%
3 Year Est. Return
+108.59%
5 Year Est. Return
+118.76%
10 Year Est. Return
+561.53%
AUM
$734B
AUM Growth
-$36.7B
Cap. Flow
+$3.56B
Cap. Flow %
0.48%
Top 10 Hldgs %
15.88%
Holding
8,241
New
197
Increased
3,111
Reduced
3,746
Closed
238

Sector Composition

Rank Sector Weight
1 Technology 17.71%
2 Healthcare 11.34%
3 Financials 9.38%
4 Consumer Discretionary 8.31%
5 Communication Services 5.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SWAN icon
6951
Amplify BlackSwan Growth & Treasure Core ETF
SWAN
$163M
$6K ﹤0.01%
227
STLN
6952
Starling Oncology, Inc. Common Stock
STLN
$644M
$6K ﹤0.01%
1,425
+222
+18% +$1.3K
YARW
6953
Yarrow Bioscience, Inc. Common Stock
YARW
$114M
$6K ﹤0.01%
26
-21
-45% -$6.72K
XSHD icon
6954
Invesco S&P SmallCap High Dividend Low Volatility ETF
XSHD
$73.3M
$6K ﹤0.01%
366
ZSL icon
6955
ProShares UltraShort Silver
ZSL
$58.5M
$6K ﹤0.01%
4
-284
-99% -$394K
XTIA icon
6956
XTI Aerospace
XTIA
$60.8M
0
GRCE
6957
Grace Therapeutics
GRCE
$43.5M
$6K ﹤0.01%
1,883
-1,228
-39% -$6.05K
IQDE
6958
DELISTED
FlexShares International Quality Dividend Defensive Index Fund
IQDE
$6K ﹤0.01%
378
-514
-58% -$9.76K
AUMN
6959
DELISTED
Golden Minerals Company
AUMN
$6K ﹤0.01%
886
-1,399
-61% -$10.2K
ALYA
6960
DELISTED
Alithya Group Inc Class A Subordinate Voting Shares
ALYA
$6K ﹤0.01%
3,000
-1,000
-25% -$2.17K
SLVR
6961
DELISTED
SilverSPAC Inc. Class A Ordinary Share
SLVR
$6K ﹤0.01%
623
+51
+9% +$496
KINZU
6962
DELISTED
KINS Technology Group Inc. Unit
KINZU
$6K ﹤0.01%
602
BRMK.WS
6963
DELISTED
Broadmark Realty Capital Inc. Warrants, each exercisable for one fourth (1/4th) share of Common Stock at an exercise price of $2.875 per quarter share
BRMK.WS
$6K ﹤0.01%
110,471
LMACA
6964
DELISTED
Liberty Media Acquisition Corporation Series A Common Stock
LMACA
$6K ﹤0.01%
575
LFTRU
6965
DELISTED
Lefteris Acquisition Corp. Unit
LFTRU
$6K ﹤0.01%
600
AMPE
6966
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$6K ﹤0.01%
355
-677
-66% -$23.7K
PTE
6967
DELISTED
PolarityTE, Inc. Common Stock
PTE
$6K ﹤0.01%
7,315
+3,066
+72% +$3.73K
NVIV
6968
DELISTED
InVivo Therapeutics Holdings Corp
NVIV
$6K ﹤0.01%
1,469
+315
+27% +$1.72K
AHI
6969
DELISTED
Advanced Health Intelligence Ltd
AHI
$6K ﹤0.01%
2,477
+302
+14% +$799
OPT
6970
DELISTED
Opthea Limited American Depositary Shares
OPT
$6K ﹤0.01%
1,000
ADTX
6971
DELISTED
ADITXT INC
ADTX
0
BIVI icon
6972
BioVie
BIVI
$12M
$5K ﹤0.01%
21
+6
+40% +$1.43K
CCEL icon
6973
Cryo-Cell International
CCEL
$31.4M
$5K ﹤0.01%
800
CGCP icon
6974
Capital Group Core Plus Income ETF
CGCP
$8.53B
$5K ﹤0.01%
+238
New +$5.53K
CSPI icon
6975
CSP Inc
CSPI
$84.8M
$5K ﹤0.01%
1,406
+6
+0.4% +$24

Similar funds

Morgan Stanley's Q3 2022 Portfolio in Review

As of Q3 2022, Morgan Stanley held 8,241 positions worth $734B, down 4.8% from $770B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Morgan Stanley's Q3 2022 filing shows 197 new, 3,111 increased, 3,746 reduced and 238 closed positions. Its largest new stake was Mondee Holdings, Inc. Class A Common Stock: 9,699,165 shares worth $75.8M. The largest sale was Amgen, an estimated $568M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Healthcare and Financials.

  • Morgan Stanley's largest Q3 2022 buy was Mondee Holdings, Inc. Class A Common Stock: 9,699,165 shares worth $75.8M.
  • Morgan Stanley added most to State Street SPDR S&P 500 ETF Trust in Q3 2022, an estimated $836M increase.
  • Morgan Stanley's biggest Q3 2022 reduction was Amgen, cutting an estimated $568M.
  • Morgan Stanley fully exited Coherent Inc in Q3 2022, selling an estimated $104M.
  • Morgan Stanley's ten largest holdings make up 16% of its $734B portfolio in Q3 2022.
  • Morgan Stanley opened 197 new positions and closed 238 in Q3 2022.
  • Morgan Stanley's portfolio value fell 4.8% quarter-over-quarter to $734B.

Based on Morgan Stanley's 13F filing for Q3 2022, filed 14 Nov 2022.